HHS awarded $350M to ZOLL MEDICAL CORPORATION for COVID-19 ventilators, a sole-source contract

Contract Overview

Contract Amount: $349,875,000 ($349.9M)

Contractor: Zoll Medical Corporation

Awarding Agency: Department of Health and Human Services

Start Date: 2020-03-30

End Date: 2020-07-31

Contract Duration: 123 days

Daily Burn Rate: $2.8M/day

Competition Type: NOT COMPETED

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: COVID-19 -VENTILATORS

Place of Performance

Location: CHELMSFORD, MIDDLESEX County, MASSACHUSETTS, 01824

State: Massachusetts Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $349.9 million to ZOLL MEDICAL CORPORATION for work described as: COVID-19 -VENTILATORS Key points: 1. The contract's value of $350 million represents a significant investment in critical medical equipment during the pandemic. 2. The sole-source nature of this award warrants scrutiny regarding the justification for not pursuing competitive bidding. 3. Performance risk appears moderate given the urgency of the COVID-19 response and the specialized nature of ventilator supply. 4. This contract positions ZOLL MEDICAL CORPORATION as a key supplier during a national health crisis. 5. The firm fixed-price structure provides cost certainty for the government, shifting cost risk to the contractor.

Value Assessment

Rating: fair

Benchmarking the value of this contract is challenging due to its emergency nature and sole-source award. However, the $350 million price tag for ventilators during the peak of the COVID-19 pandemic suggests a premium was likely paid to ensure rapid delivery and availability. Without competitive bids, it's difficult to definitively assess if this represents optimal value for money compared to what could have been achieved through a competitive process. The firm fixed-price contract does offer predictability in cost.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning that only one vendor, ZOLL MEDICAL CORPORATION, was solicited. The justification for this approach likely stemmed from the urgent need for ventilators during the COVID-19 public health emergency, where time was of the essence and existing relationships or specialized capabilities may have been prioritized. The lack of competition means that price discovery through market forces was bypassed.

Taxpayer Impact: The absence of competition means taxpayers may have paid a higher price than if multiple vendors had bid. It also limits the government's ability to leverage market dynamics to secure the best possible terms and pricing.

Public Impact

The primary beneficiaries are patients requiring mechanical ventilation due to severe respiratory illness, particularly those affected by COVID-19. The contract ensures the supply of critical medical equipment to support the nation's healthcare infrastructure during a pandemic. The geographic impact is national, aiming to distribute ventilators to areas with the greatest need. This contract supports the workforce within ZOLL MEDICAL CORPORATION and its supply chain, ensuring continued operations and production.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

The medical device sector, particularly respiratory equipment, experienced unprecedented demand during the COVID-19 pandemic. This contract falls within the 'Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers' category. Spending in this sector surged globally to meet emergency needs. Comparable spending benchmarks are difficult to establish due to the unique market conditions and emergency procurement methods employed during the pandemic.

Small Business Impact

This contract was awarded directly to ZOLL MEDICAL CORPORATION and does not appear to have specific small business set-aside provisions. There is no explicit information regarding subcontracting plans with small businesses. The focus was on securing a large volume of critical equipment rapidly from an established manufacturer, which may limit opportunities for smaller suppliers in this specific transaction.

Oversight & Accountability

Oversight for this contract would fall under the Department of Health and Human Services (HHS), specifically the Office of Assistant Secretary for Preparedness and Response (ASPR). Given the emergency nature, oversight might have focused on delivery timelines and product specifications. Transparency is limited due to the sole-source award. Inspector General involvement would depend on any reported issues or audits related to contract performance or pricing.

Related Government Programs

Risk Flags

Tags

healthcare, hhs, aspr, medical-equipment, ventilators, covid-19, definitive-contract, firm-fixed-price, sole-source, emergency-procurement, massachusetts, national

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $349.9 million to ZOLL MEDICAL CORPORATION. COVID-19 -VENTILATORS

Who is the contractor on this award?

The obligated recipient is ZOLL MEDICAL CORPORATION.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).

What is the total obligated amount?

The obligated amount is $349.9 million.

What is the period of performance?

Start: 2020-03-30. End: 2020-07-31.

What was the specific justification for awarding this contract on a sole-source basis?

The contract was awarded on a sole-source basis due to the urgent and critical need for ventilators during the COVID-19 public health emergency. The justification likely centered on the immediate requirement to procure life-saving equipment rapidly, where the government determined that soliciting competitive proposals would cause undue delay and jeopardize national health security. ZOLL MEDICAL CORPORATION was likely identified as a capable and available supplier able to meet the immediate demand, potentially based on existing capabilities, production capacity, or prior relationships.

How does the unit cost of these ventilators compare to pre-pandemic market rates or other government contracts?

Direct comparison of unit costs is challenging without access to specific pricing details and the exact model of ventilators procured. However, during the height of the pandemic, demand for ventilators surged globally, leading to significant price increases across the market. Emergency procurements, especially sole-source ones, often incur a premium to ensure rapid delivery and secure supply. Without competitive bidding, it's difficult to ascertain if the price paid was at market rate, a premium, or a favorable emergency rate.

What are the potential risks associated with relying on a single supplier for such a critical need?

Relying on a single supplier, as in this sole-source contract, introduces several risks. Firstly, it creates a dependency that can be problematic if the supplier faces production issues, quality control problems, or supply chain disruptions. Secondly, it eliminates the competitive pressure that typically drives down prices and encourages innovation. Taxpayers may have paid more than necessary, and the government has limited recourse if the supplier fails to meet expectations beyond contractual remedies. This also concentrates risk in one entity for a critical national need.

What was the total number of ventilators procured under this contract?

The provided data indicates a total award amount of $349,875,000 but does not specify the exact quantity of ventilators procured. The contract type is 'FIRM FIXED PRICE,' suggesting a set price for the goods delivered. To determine the quantity, one would need to know the per-unit price agreed upon in the contract. Without that information, the total number of ventilators remains unknown from the given data points.

What is ZOLL MEDICAL CORPORATION's track record with government contracts, particularly for emergency medical supplies?

ZOLL MEDICAL CORPORATION is a well-established company specializing in medical devices, including ventilators and resuscitation equipment. While specific details on their historical government contract performance for emergency supplies are not provided here, their selection for this significant sole-source award suggests a recognized capability and capacity to meet critical needs. Companies in this sector often have prior experience with government agencies, especially during health crises, due to the nature of their products.

Were there any performance issues or delays encountered during the contract period (March 30, 2020 - July 31, 2020)?

The provided data indicates the contract was awarded on March 30, 2020, and had an end date of July 31, 2020, a duration of approximately four months during the initial surge of the COVID-19 pandemic. While the data does not explicitly detail performance issues or delays, the urgency of the situation and the sole-source nature suggest the primary focus was rapid delivery. Any significant performance issues would typically be documented in contract performance reports or through Inspector General investigations, which are not detailed in this summary.

Industry Classification

NAICS: Wholesale TradeProfessional and Commercial Equipment and Supplies Merchant WholesalersMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: NOT COMPETED

Solicitation Procedures: ONLY ONE SOURCE

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Asahi Kasei Corporation (UEI: 690535364)

Address: 269 MILL RD, CHELMSFORD, MA, 01824

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $349,875,000

Exercised Options: $349,875,000

Current Obligation: $349,875,000

Actual Outlays: $349,875,000

Contract Characteristics

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline

Start Date: 2020-03-30

Current End Date: 2020-07-31

Potential End Date: 2020-08-22 00:00:00

Last Modified: 2020-08-17

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending